Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$24.15 - $31.95 $3.14 Million - $4.16 Million
-130,200 Reduced 81.27%
30,000 $872,000
Q4 2023

Feb 14, 2024

BUY
$18.07 - $29.37 $1.09 Million - $1.77 Million
60,200 Added 60.2%
160,200 $4.42 Million
Q3 2023

Nov 14, 2023

SELL
$22.41 - $41.99 $856,062 - $1.6 Million
-38,200 Reduced 27.64%
100,000 $2.24 Million
Q2 2023

Aug 14, 2023

BUY
$40.4 - $59.1 $5.58 Million - $8.17 Million
138,200 New
138,200 $5.62 Million
Q4 2022

Feb 14, 2023

BUY
$33.53 - $54.79 $4.64 Million - $7.58 Million
138,400 Added 461.33%
168,400 $6.43 Million
Q2 2022

Aug 15, 2022

BUY
$25.6 - $45.23 $768,000 - $1.36 Million
30,000 New
30,000 $1.2 Million
Q1 2022

May 13, 2022

SELL
$33.33 - $44.6 $999,900 - $1.34 Million
-30,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$37.01 - $44.74 $2.22 Million - $2.68 Million
-60,000 Reduced 66.67%
30,000 $1.12 Million
Q2 2021

Aug 16, 2021

BUY
$37.95 - $49.37 $3.42 Million - $4.44 Million
90,000 New
90,000 $3.81 Million
Q4 2020

Feb 16, 2021

SELL
$47.96 - $67.64 $1.44 Million - $2.03 Million
-30,000 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$33.82 - $48.17 $1.29 Million - $1.83 Million
-38,000 Reduced 55.88%
30,000 $1.02 Million
Q2 2019

Aug 13, 2019

BUY
$35.42 - $45.0 $1.13 Million - $1.44 Million
32,000 Added 88.89%
68,000 $3.06 Million
Q1 2019

May 14, 2019

SELL
$28.09 - $39.49 $393,260 - $552,860
-14,000 Reduced 28.0%
36,000 $1.35 Million
Q3 2018

Nov 14, 2018

BUY
$33.9 - $47.77 $1.1 Million - $1.55 Million
32,500 Added 185.71%
50,000 $2.35 Million
Q2 2018

Aug 14, 2018

BUY
$25.7 - $47.88 $449,750 - $837,900
17,500 New
17,500 $591,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.03B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.